New Alerts Needed for ADHD drugs

by Medindia Content Team on  August 22, 2006 at 1:09 PM Drug News   - G J E 4
New Alerts Needed for ADHD drugs
Most attention deficit hyperactivity disorder drugs should include new warnings about the risk of psychotic behavior, heart problems and sudden death, according to U.S. health officials on Monday.

These drugs include Novartis AG's Ritalin and GlaxoSmithKline Plc's, Dexedrine, Food and Drug Administration spokeswoman, Susan Bro said.

She said that these stimulant drugs, stimulants can raise blood pressure. They must also include warnings about the risk of behavioral problems such as aggression and mania.

Bro was not able to confirm whether other ADHD drugs -- Eli Lilly and Co.'s Strattera and Johnson & Johnson's Concerta were also ordered to carry the warnings.

Strattera already includes a warning about suicidal thoughts, while Shire Plc's Adderall already carries a warning that misuse can cause heart problems.

The FDA's decision follows months after conflicting opinions were offered by two separate panels of outside experts on whether the risks warranted the need for the 'black box', the strongest warnings possible.

Although Bro could not confirm whether the heart warning was boxed, a letter from Glaxo said the heart caution was a boxed warning. In addition other non-boxed warnings such as psychotic behavior, stunted growth, seizures and vision problems were also included.

Glaxo is also reported to have agreed with the FDA's request to add the warning language, compiling with the agency's recommended wording.

Concerns whether the new warnings could dampen use of the medicines was expressed by several doctors. The FDA has estimated that presently about 1 million prescriptions for adults and 2 million for children are seen each month. The necessity of many of these prescriptions is still under question with critics pointing out that the drugs are over used.

In May, Canadian health authorities publicly warned people with high blood pressure, heart disease and other medical problems to avoid taking medications for ADHD.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
I took zyprexa which was ineffective for my condition and gave me diabetes. Zyprexa, which is used for the treatment of psychiatric disorders, such as schizophrenia and bipolar disorder, accounted for 32% of Eli Lilly's $14.6 billion revenue last year. Zyprexa is the product name for Olanzapine,it is Lilly's top selling drug.It was approved by the FDA in 1996 ,an 'atypical' antipsychotic a newer class of drugs without the motor side effects of the older Thorazine.Zyprexa has been linked to causing diabetes and pancreatitis. Did you know that Lilly made nearly $3 billion last year on diabetic meds, Actos,Humulin and Byetta? Yes! They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place! I was prescribed Zyprexa from 1996 until 2000. In early 2000 i was shocked to have an A1C test result of 13.9 (normal is 4-6) I have no history of diabetes in my family. ---- Daniel Haszard
guest Tuesday, August 22, 2006

You May Also Like

View All